Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oncotype DX in BRCA-mutated Breast Cancer Patients: Our Experience. A Retrospective Observational Monocentric Study

NCT06484725 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06484725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06484725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oncotype DX in BRCA-mutated Breast Cancer Patients: Our Experience. A Retrospective Observational Monocentric Study
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Completed
Start date
January 1, 2012
Completion date
June 30, 2022
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, genetic predisposition